Cengiz Ozcan1, Onur Ismi2. 1. Department of Otorhinolaryngology, School of Medicine, Mersin University, Mersin, Turkey. cozcan@mersin.edu.tr. 2. Department of Otorhinolaryngology, School of Medicine, Mersin University, Mersin, Turkey.
Abstract
PURPOSE OF REVIEW: Rhinitis is a common clinical entity. Besides nasal obstruction, itching, and sneezing, one of the most important symptoms of rhinitis is nasal hypersecretion produced by nasal glands and exudate from the nasal vascular bed. Allergic rhinitis is an IgE-mediated inflammatory reaction of nasal mucosa after exposure to environmental allergens. Idiopathic rhinitis describes rhinitis symptoms that occur after non-allergic, noninfectious irritants. Specific allergen avoidance, topical nasal decongestants, nasal corticosteroids, immunotherapy, and sinonasal surgery are the main treatment options. Because the current treatment modalities are not enough for reducing rhinorrhea in some patients, novel treatment options are required to solve this problem. RECENT FINDINGS: Botulinum toxin is an exotoxin generated by Clostridium botulinum. It disturbs the signal transmission at the neuromuscular and neuroglandular junction by inhibiting the acetylcholine release from the presynaptic nerve terminal. It has been widely used in neuromuscular, hypersecretory, and autonomic nerve system disorders. There have been a lot of published articles concerning the effect of this toxin on rhinitis symptoms. Based on the results of these reports, intranasal botulinum toxin A administration appears to be a safe and effective treatment method for decreasing rhinitis symptoms in rhinitis patients with a long-lasting effect. Botulinum toxin type A will be a good treatment option for the chronic rhinitis patients who are resistant to other treatment methods.
PURPOSE OF REVIEW: Rhinitis is a common clinical entity. Besides nasal obstruction, itching, and sneezing, one of the most important symptoms of rhinitis is nasal hypersecretion produced by nasal glands and exudate from the nasal vascular bed. Allergic rhinitis is an IgE-mediated inflammatory reaction of nasal mucosa after exposure to environmental allergens. Idiopathic rhinitis describes rhinitis symptoms that occur after non-allergic, noninfectious irritants. Specific allergen avoidance, topical nasal decongestants, nasal corticosteroids, immunotherapy, and sinonasal surgery are the main treatment options. Because the current treatment modalities are not enough for reducing rhinorrhea in some patients, novel treatment options are required to solve this problem. RECENT FINDINGS: Botulinum toxin is an exotoxin generated by Clostridium botulinum. It disturbs the signal transmission at the neuromuscular and neuroglandular junction by inhibiting the acetylcholine release from the presynaptic nerve terminal. It has been widely used in neuromuscular, hypersecretory, and autonomic nerve system disorders. There have been a lot of published articles concerning the effect of this toxin on rhinitis symptoms. Based on the results of these reports, intranasal botulinum toxin A administration appears to be a safe and effective treatment method for decreasing rhinitis symptoms in rhinitispatients with a long-lasting effect. Botulinum toxin type A will be a good treatment option for the chronic rhinitispatients who are resistant to other treatment methods.
Authors: Tarik Sapci; Sara Yazici; M Fatih Evcimik; Ziya Bozkurt; Ahmet Karavus; Bayram Ugurlu; Emre Ozkurt Journal: Rhinology Date: 2008-03 Impact factor: 3.681
Authors: Dale Ehmer; Chad M McDuffie; J Bradley McIntyre; Bryan M Davis; Neelesh H Mehendale; John H Willis; Jeremy P Watkins; V Vasu Kakarlapudi Journal: Allergy Rhinol (Providence) Date: 2022-05-29
Authors: Skyla A Duncan; Dieudonné R Baganizi; Rajnish Sahu; Shree R Singh; Vida A Dennis Journal: Front Microbiol Date: 2017-12-12 Impact factor: 5.640
Authors: J Pablo Stolovitzky; Randall A Ow; Stacey L Silvers; Nadim B Bikhazi; Curtis D Johnson; Masayoshi Takashima Journal: OTO Open Date: 2021-09-10